The global animal vaccines market is segmented based on various products, technologies and animal diseases. Product segment covers companion animal vaccines, poultry, livestock, porcine, aquaculture and equine. The companion animal vaccine sub-segment is further sub-divided into feline vaccines and canine vaccines. The livestock vaccines sub-segment includes bovine vaccines and ruminant vaccines. The livestock vaccines are the largest sub-segment in global animal vaccines market. However, companion vaccine and aquaculture are fastest growing sub-segments in global animal vaccines market.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market/report-sample
Based on technology, the market is segmented into live attenuated vaccines, subunit vaccines, in-activated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines and DNA vaccines. DNA vaccine is the fastest growing technology in global animal vaccines market. This is due to factors such as thermo-stability, easy production, cost effectiveness and rapid development against emerging diseases. The animal diseases segment covers rabies, foot and mouth disease, avian influenza, gumboro disease and strangles.
However, patent expiry of various major vaccines and increasing maintenance costs for vaccines are key restraints of this market. Stringent regulations and legislations and shift towards vegetarian food by consumers also obstruct the growth of global animal vaccines market. Rapid product launches and increasing mergers and acquisitions between vaccines manufactures are emerging trends of the global animal vaccines market.
Browse report at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market
Some of the major competitors in the market include Pfizer, Sanofi-Aventis, Bayer HealthCare, Novartis, Boehringer Ingelheim, Ceva, Heska Corporation, Bioniche Animal Health Canada Inc. and Virbac.
Explore report sample at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market/report-sample
Based on technology, the market is segmented into live attenuated vaccines, subunit vaccines, in-activated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines and DNA vaccines. DNA vaccine is the fastest growing technology in global animal vaccines market. This is due to factors such as thermo-stability, easy production, cost effectiveness and rapid development against emerging diseases. The animal diseases segment covers rabies, foot and mouth disease, avian influenza, gumboro disease and strangles.
However, patent expiry of various major vaccines and increasing maintenance costs for vaccines are key restraints of this market. Stringent regulations and legislations and shift towards vegetarian food by consumers also obstruct the growth of global animal vaccines market. Rapid product launches and increasing mergers and acquisitions between vaccines manufactures are emerging trends of the global animal vaccines market.
Browse report at: https://www.psmarketresearch.com/market-analysis/animal-vaccines-market
Some of the major competitors in the market include Pfizer, Sanofi-Aventis, Bayer HealthCare, Novartis, Boehringer Ingelheim, Ceva, Heska Corporation, Bioniche Animal Health Canada Inc. and Virbac.
About
P&S Intelligence
P&S
Intelligence, a brand of P&S Market Research, is a provider of market
research and consulting services catering to the market information needs of
burgeoning industries across the world. Providing the plinth of market
intelligence, P&S as an enterprising research and consulting company,
believes in providing thorough landscape analyses on the ever-changing market
scenario, to empower companies to make informed decisions and base their
business strategies with astuteness.
Contact:
P&S Intelligence
Toll-free: +1-888-778-7886
(USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Connect with us: LinkedIn | Twitter | Google + | Facebook
0 Comments